{"text": ["Cramer&apos;s", "lightning", "round:", "Mercadolibre", "is", "even", "better", "than", "eBay", "was"], "created_at": "2018-01-08 23:50:09"}
{"text": ["Cramer's", "lightning", "round:", "Mercadolibre", "is", "even", "better", "than", "eBay", "was"], "created_at": "2018-01-08 23:50:09"}
{"text": ["Galapagos", "Reports", "Topline", "Data", "From", "Osteoarthritis", "Study"], "created_at": "2018-01-08 17:07:33"}
{"text": ["Understanding", "AbbVie\u2019s", "Positive", "Upadacitinib", "Data", "for", "Atopic", "Dermatitis"], "created_at": "2018-01-08 15:32:55"}
{"text": ["US", "STOCKS-Wall", "St", "new", "year", "rally", "pauses", "as", "healthcare,", "bank", "stocks", "weigh"], "created_at": "2018-01-08 15:03:54"}
{"text": ["Galapagos", "Reports", "Topline", "Data", "From", "Osteoarthritis", "Study"], "created_at": "2018-01-08 15:02:03"}
{"text": ["Why", "AbbVie\u2019s", "Upadacitinib", "Keeps", "Posting", "Strong", "Data", "for", "Rheumatoid", "Arthritis"], "created_at": "2018-01-08 14:03:35"}
{"text": ["AbbVie's", "Upadacitinib", "Granted", "Breakthrough", "Therapy", "Designation", "from", "the", "U.S.", "Food", "and", "Drug", "Administration", "for", "Atopic", "Dermatitis"], "created_at": "2018-01-08 13:00:00"}
{"text": ["What", "Upadacitinib", "Did", "for", "AbbVie", "in", "2017"], "created_at": "2018-01-08 12:35:59"}
{"text": ["This", "Is", "Expected", "to", "Boost", "AbbVie\u2019s", "Growth", "Prospects"], "created_at": "2018-01-08 06:13:53"}
{"text": ["Why", "Humira", "Is", "Still", "a", "Solid", "Growth", "Driver", "for", "AbbVie", "in", "2018"], "created_at": "2018-01-08 06:13:52"}
{"text": ["How", "Increasing", "Biologic", "Penetration", "Could", "Boost", "AbbVie\u2019s", "Revenues"], "created_at": "2018-01-08 06:13:52"}
